strata skin sciences inc - SSKN

SSKN

Close Chg Chg %
0.32 -0.13 -39.99%

Closed Market

0.19

-0.13 (39.99%)

Volume: 4.04M

Last Updated:

Feb 18, 2026, 4:00 PM EDT

Company Overview: strata skin sciences inc - SSKN

SSKN Key Data

Open

$0.28

Day Range

0.18 - 0.28

52 Week Range

0.18 - 3.86

Market Cap

$1.18M

Shares Outstanding

5.89M

Public Float

3.93M

Beta

0.34

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$1.53

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.13M

 

SSKN Performance

No Data Available

SSKN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About strata skin sciences inc - SSKN

STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. It engages in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through the following segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. The Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. The company was founded by Dina Gutkowicz-Krusin in December 1989 and is headquartered in Horsham, PA.

SSKN At a Glance

STRATA Skin Sciences, Inc.
5 Walnut Grove Drive
Horsham, Pennsylvania 19044
Phone 1-215-619-3200 Revenue 30.70M
Industry Medical Specialties Net Income -6,261,000.00
Sector Health Technology Employees 114
Fiscal Year-end 12 / 2026
View SEC Filings

SSKN Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.191
Price to Book Ratio 2.551
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -10.392
Enterprise Value to Sales 0.463
Total Debt to Enterprise Value 1.144

SSKN Efficiency

Revenue/Employee 269,263.158
Income Per Employee -54,921.053
Receivables Turnover 7.449
Total Asset Turnover 0.907

SSKN Liquidity

Current Ratio 0.583
Quick Ratio 0.478
Cash Ratio 0.296

SSKN Profitability

Gross Margin 58.252
Operating Margin -19.009
Pretax Margin -20.358
Net Margin -20.397
Return on Assets -18.494
Return on Equity -158.909
Return on Total Capital -32.65
Return on Invested Capital -50.739

SSKN Capital Structure

Total Debt to Total Equity 559.422
Total Debt to Total Capital 84.835
Total Debt to Total Assets 52.882
Long-Term Debt to Equity 23.659
Long-Term Debt to Total Capital 3.588
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Strata Skin Sciences Inc - SSKN

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
36.16M 33.36M 33.56M 30.70M
Sales Growth
+20.63% -7.75% +0.61% -8.54%
Cost of Goods Sold (COGS) incl D&A
14.39M 14.90M 14.48M 12.81M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
5.69M 5.90M 5.31M 4.47M
Depreciation
2.79M 3.20M 3.31M 3.27M
Amortization of Intangibles
2.90M 2.70M 2.00M 1.20M
COGS Growth
+42.13% +3.50% -2.79% -11.50%
Gross Income
21.77M 18.46M 19.08M 17.88M
Gross Income Growth
+9.66% -15.19% +3.36% -6.29%
Gross Profit Margin
+60.20% +55.34% +56.85% +58.25%
2022 2023 2024 2025 5-year trend
SG&A Expense
26.42M 24.78M 24.48M 23.72M
Research & Development
1.03M 1.32M 883.00K 421.00K
Other SG&A
25.39M 23.46M 23.59M 23.30M
SGA Growth
+8.93% -6.19% -1.23% -3.10%
Other Operating Expense
- - - -
-
Unusual Expense
- 3.19M 3.86M (1.14M)
EBIT after Unusual Expense
(4.65M) (9.51M) (9.26M) (4.70M)
Non Operating Income/Expense
89.00K 231.00K 1.11M 410.00K
Non-Operating Interest Income
89.00K 231.00K 242.00K 410.00K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
926.00K 1.64M 2.11M 1.96M
Interest Expense Growth
+194.90% +77.11% +28.48% -7.02%
Gross Interest Expense
926.00K 1.64M 2.11M 1.96M
Interest Capitalized
- - - -
-
Pretax Income
(5.49M) (10.92M) (10.26M) (6.25M)
Pretax Income Growth
-105.31% -99.09% +6.10% +39.07%
Pretax Margin
-15.17% -32.74% -30.56% -20.36%
Income Tax
63.00K (92.00K) (170.00K) 12.00K
Income Tax - Current - Domestic
23.00K 28.00K 16.00K 12.00K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- 40.00K (120.00K) (186.00K)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(5.55M) (10.83M) (10.09M) (6.26M)
Minority Interest Expense
- - - -
-
Net Income
(5.55M) (10.83M) (10.09M) (6.26M)
Net Income Growth
-105.06% -95.17% +6.87% +37.92%
Net Margin Growth
-15.35% -32.47% -30.05% -20.40%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(5.55M) (10.83M) (10.09M) (6.26M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(5.55M) (10.83M) (10.09M) (6.26M)
EPS (Basic)
-1.5986 -3.1013 -2.6492 -1.3463
EPS (Basic) Growth
-101.16% -94.00% +14.58% +49.18%
Basic Shares Outstanding
3.47M 3.49M 3.81M 4.65M
EPS (Diluted)
-1.5986 -3.1013 -2.6492 -1.3463
EPS (Diluted) Growth
-101.16% -94.00% +14.58% +49.18%
Diluted Shares Outstanding
3.47M 3.49M 3.81M 4.65M
EBITDA
1.04M (418.00K) (87.00K) (1.37M)
EBITDA Growth
+428.80% -140.23% +79.19% -1,472.41%
EBITDA Margin
+2.87% -1.25% -0.26% -4.46%

Strata Skin Sciences Inc in the News